The Eppley Institute for Research in Cancer and Allied Diseases is a research institute at the University of Nebraska Medical Center in Omaha, Nebraska, United States.
In 1968, Dr. Philippe Shubik's research group moved to UNMC from the Chicago Medical School to continue their focus on the study of chemical carcinogenesis.
It has access to 734 beds and handles 22,000 inpatient admissions yearly for approximately 3,600 new cancer patients annually.
[citation needed] 164 Cancer Center members, including 61 practicing physicians, are involved in basic, clinical, and population-based research and are awarded approximately $20 million in peer-reviewed research grants annually.
[4] Eppley is recognized for its treatments of hematological malignancies, particularly lymphomas and leukemia.